PCOS Has Been Renamed PMOS — And It Changes Everything About How We Should Treat It
Photo by Yuris Alhumaydy on Unsplash.
If you've been diagnosed with PCOS, you may have recently seen the news: the name has changed.
In May 2026, a global consensus of 56 leading clinical and academic organisations — published in The Lancet — officially renamed polycystic ovary syndrome to polyendocrine metabolic ovarian syndrome, or PMOS. It's being described as a landmark shift. And while a name change might sound like a technicality, this one matters. It fundamentally changes how the condition should be understood and treated.
Here's why.
The problem with "polycystic"
The old name did real harm. It implied the condition was primarily about cysts on the ovaries, which led generations of women to be told they had PCOS based on an ultrasound showing what appeared to be cysts, then offered the contraceptive pill or metformin and sent on their way.
The problem is that those "cysts" aren't actually cysts. They're arrested follicles — eggs that started developing but didn't complete ovulation. They're a consequence of something happening upstream, not the condition itself. And the name meant that the upstream drivers were rarely the focus of treatment.
The new name tells a different story.
What "polyendocrine metabolic" actually means
PMOS is now recognised as a complex, multisystem condition involving endocrine, metabolic, reproductive, dermatological, and psychological health. Not a gynaecological disorder with some metabolic features, but a metabolic and endocrine condition that affects the whole system. It affects 1 in 8 women worldwide — more than 170 million people — and the renaming process drew responses from over 14,300 patients and healthcare professionals across every world region.
"Polyendocrine" means multiple hormonal systems are involved: not just reproductive hormones like oestrogen, LH, and FSH, but also insulin, androgens (like testosterone), cortisol, and thyroid hormones. These systems don't operate in isolation. In PMOS, they interact in ways that create a self-reinforcing pattern: elevated androgens affect insulin sensitivity, insulin resistance drives androgen production, stress hormones disrupt ovulation, and inflammation compounds all of it.
"Metabolic" recognises that insulin resistance is central to the condition for the majority of people, not a side effect or complication, but a core driver. This is true even in people who aren't overweight, which is why the old framing (and the common advice to "just lose weight") so often missed the point entirely.
Why this matters for treatment
If PMOS is a multisystem metabolic condition, then treating it as a reproductive problem (suppressing symptoms with the pill, or managing insulin with metformin alone) addresses the output without touching the input.
The contraceptive pill doesn't treat PMOS. It masks the hormonal patterns while the underlying drivers continue. When people come off it, the symptoms return, often worse, because nothing has changed in the biology that was driving them.
This doesn't mean medication is never appropriate. But it does mean that medication alone, without addressing the metabolic and endocrine picture, is unlikely to produce lasting change.
What actually moves the picture is looking at the whole system: insulin metabolism, inflammatory load, stress physiology and cortisol patterns, gut function and microbiome health, nutrient status (particularly those that support androgen metabolism and ovulation), sleep, and where relevant, the role of genetics in how your body processes hormones and nutrients.
This is exactly what the name change is pointing toward.
What this looks like in practice
A whole-systems approach to PMOS starts with understanding which drivers are most active for you, because the condition presents differently in different people and the intervention needs to reflect that.
For some people, insulin resistance is the dominant driver and stabilising blood sugar is the priority. For others, the picture is more inflammatory, or stress physiology is significantly disrupting the HPA axis and suppressing ovulation. For others still, nutrient insufficiencies, particularly in minerals and B vitamins involved in hormone metabolism, are maintaining the pattern.
The aim is to identify the pattern, address the drivers in the right sequence, and support the conditions in which the body can regulate itself.
Improvements in cycle regularity, ovulation, skin, energy, mood, and fertility are all possible, but they come from working with the biology, not around it.
Working with PMOS in Ballarat and Daylesford
I work with people navigating PMOS and the hormonal, metabolic, and psychological complexity that comes with it, in person in Ballarat and Daylesford, and online across Australia and internationally.
If you'd like to understand what's driving your symptoms and what a whole-systems approach might look like for you, a personalised consult is the place to start.
Not sure yet?